Please provide your email address to receive an email when new articles are posted on . Direct-acting antivirals for hepatitis C have dominated hepatitis research for the past decade and have ...
This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the sixth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...
Please provide your email address to receive an email when new articles are posted on . Healio spoke with Meg Doherty, MD, MPH, PhD, Director Global HIV, Hepatitis and STI Programmes at WHO, about ...
In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients ...
In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV). Now real-world studies of patients ...
Viral hepatitis is a serious health condition that affects the liver. While hepatitis B and C viruses are commonly targeted by public health measures aiming to reduce the disease burden, there is ...
A new review published on JAMA Network discusses the magnitude of the current hepatitis D virus (HDV) epidemic and its implications for public health. HDV is a small ribonucleic acid (RNA) virus that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results